Sources | Names Used |
---|---|
GDSC1000 | QL-VIII-58 |
PharmacoGx | QL-VIII-58 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GLS2 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0003 |
mRNA | TNKS1BP1 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0003 |
mRNA | LGALS1 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0003 |
mRNA | SYT13 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0003 |
mRNA | SNX24 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0003 |
mRNA | LAMB2 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0003 |
mRNA | C20orf194 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0003 |
mRNA | PTK7 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0003 |
mRNA | JARID2 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0004 |
mRNA | GLTPD2 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0004 |